{
    "clinical_study": {
        "@rank": "107645", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D (600 IU)", 
                "arm_group_type": "Experimental", 
                "description": "Daily oral dose for 12 months"
            }, 
            {
                "arm_group_label": "Vitamin D (2000 IU)", 
                "arm_group_type": "Experimental", 
                "description": "Daily oral dose for 12 months"
            }, 
            {
                "arm_group_label": "Vitamin D (4000 IU)", 
                "arm_group_type": "Experimental", 
                "description": "Daily oral dose for 12 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Daily oral dose for 12 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this study is to understand the effects of vitamin D supplementation on\n      immunological outcomes among patients with tuberculosis."
        }, 
        "brief_title": "Vitamin D Supplementation and TB", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Tuberculosis", 
            "Vitamin D", 
            "Immunity"
        ], 
        "condition_browse": {
            "mesh_term": "Tuberculosis"
        }, 
        "detailed_description": {
            "textblock": "In this randomized trial, the investigators will enroll 200 adults with active pulmonary\n      tuberculosis (TB; among whom 40 have HIV co-infections) at the time of TB diagnosis in S\n      India. The intervention will include daily vitamin D supplementation in 3 treatment arms\n      (600, 2000, and 4000 IU vitamin D), compared to placebo, for 12 months. The investigators'\n      primary objectives are to assess how vitamin D supplementation affects immunity\n      (immunological markers, immune competence) and serum vitamin D levels. Secondary outcomes\n      include TB treatment outcomes (successful sputum smear conversion, relapse) in all patients,\n      and human immunodeficiency virus (HIV) disease progression among a subset of patients with\n      HIV co-infection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Active TB diagnosis by GeneXpert\n\n          -  HIV infection status (according to AMC HIV clinic medical records of enzyme-linked\n             immunosorbent assay [ELISA] results)\n\n        Exclusion Criteria:\n\n          -  Children (<18 years of age)\n\n          -  60 years of age\n\n          -  Pregnant at baseline\n\n          -  Other severe complications or illnesses requiring hospitalization\n\n          -  Received TB treatment for greater than 4 weeks in the past 5 years\n\n          -  Refused to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01992263", 
            "org_study_id": "IRB #: 1304003801"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D (600 IU)", 
                "intervention_name": "Vitamin D (600 IU)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Vitamin D (2000 IU)", 
                "intervention_name": "Vitamin D (2000 IU)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Vitamin D (4000 IU)", 
                "intervention_name": "Vitamin D (4000 IU)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "tuberculosis", 
            "vitamin D", 
            "immunity"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "location": [
            {
                "contact": {
                    "email": "eay27@cornell.edu", 
                    "last_name": "Elaine Yu, MPH", 
                    "phone": "714-478-8599"
                }, 
                "facility": {
                    "address": {
                        "city": "Ithaca", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14853"
                    }, 
                    "name": "Cornell University"
                }, 
                "investigator": {
                    "last_name": "Saurabh Mehta, ScD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "johnkennet@gmail.com", 
                    "last_name": "John Kenneth, MBBS"
                }, 
                "facility": {
                    "address": {
                        "city": "Bangalore", 
                        "country": "India"
                    }, 
                    "name": "St. John's Research Institute (SJRI)"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "wesleywesleyamc@yahoo.co.in", 
                    "last_name": "Bonam Wesley, MBBS"
                }, 
                "facility": {
                    "address": {
                        "city": "Madanapalle", 
                        "country": "India"
                    }, 
                    "name": "Arogyavaram Medical Centre (AMC)"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "India"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Trial of Vitamin D Supplementation Among Tuberculosis Patients in South India", 
        "overall_contact": {
            "email": "smehta@cornell.edu", 
            "last_name": "Saurabh Mehta, ScD", 
            "phone": "607-255-2640"
        }, 
        "overall_contact_backup": {
            "email": "eay27@cornell.edu", 
            "last_name": "Elaine Yu, MPH", 
            "phone": "714-478-8599"
        }, 
        "overall_official": {
            "affiliation": "St. John's Research Institute (SJRI)", 
            "last_name": "John Kenneth, MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "India: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Immune responses will be assessed by the superoxide bursts and proteolytic capacities of macrophages and monocytes. Activity indexes will be assessed by comparing mean substrate and calibration fluorescence.", 
                "measure": "Immune function", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "measure": "Cell-mediated immunological markers (T cells)", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "measure": "Serum 25(OH)D concentrations", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01992263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "TB treatment outcomes", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "measure": "HIV disease progression", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }
        ], 
        "source": "Cornell University", 
        "sponsors": {
            "collaborator": {
                "agency": "St. John's Research Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}